The Free-Market Defense of Science Donations

Getting your Trinity Audio player ready...

Science donations do not contradict free-market economics. They solve a problem that markets themselves reveal: valuable scientific knowledge is often underproduced because its social benefits cannot be fully captured by the person or organization that pays for it.

In economic terms, fundamental research frequently produces positive externalities and public goods. A discovery may help thousands of businesses, researchers, developers, patients, and consumers, while the original researcher receives only a small fraction of the resulting value. Voluntary donations, decentralized funding platforms, prizes, foundations, and research DAOs can help close this gap without requiring research to be controlled exclusively by either corporations or government agencies.

The free-market case for donating to science is therefore straightforward:

A functioning market economy needs a continuous supply of knowledge, but ordinary commercial investment systematically underfunds knowledge that cannot be easily owned, restricted, or monetized.

Science donations strengthen markets by financing this missing layer.

Why Markets Underproduce Scientific Knowledge

A conventional market works best when a producer can charge consumers for a clearly defined good. A company manufactures a product, excludes non-payers from using it, and earns revenue from customers who value it.

Scientific knowledge behaves differently.

Once a theorem, algorithm, experimental method, dataset, or scientific explanation becomes public, many people can use it simultaneously. One person’s use does not necessarily reduce its availability to others. Moreover, preventing others from learning from published knowledge may be difficult or socially undesirable.

Economists describe goods with these properties as partially or fully:

• Non-rivalrous: one person’s use does not consume the knowledge.
• Non-excludable: preventing non-payers from benefiting may be difficult.
• Spillover-producing: benefits extend beyond the original buyer and seller.

The World Bank notes that innovation creates knowledge with characteristics of a public good, particularly in upstream research. The OECD similarly states that long-term scientific investment underpins technological development and effective innovation systems.

Consider a mathematician who proves a foundational theorem. The theorem may later improve cryptography, artificial intelligence, logistics, physics, or engineering. Yet the mathematician usually cannot collect a fee from every company that eventually benefits.

The market price paid to the mathematician may therefore be far below the theorem’s total social value.

This is not evidence that markets are useless. It is a specific and well-understood market-allocation problem: private returns and social returns diverge.

Positive Externalities Create a Funding Gap

Suppose a research project costs $100,000 and produces $1 million in total benefits across society. However, the funder can capture only $30,000 of that value through patents, subscriptions, consulting, or product sales.

From society’s perspective, the project is worthwhile:

[
$1{,}000{,}000 – $100{,}000 = $900{,}000
]

From the private investor’s perspective, it is a loss:

[
$30{,}000 – $100{,}000 = -$70{,}000
]

A profit-seeking investor will rationally reject the project even though the project would make the economy more productive overall.

This is the central reason scientific research can be underfunded. The investor is not irrational, greedy, or anti-scientific. The investment simply cannot capture enough of the value it creates.

Research on basic-science spillovers supports this distinction between private incentives and wider economic benefits. Work published by the National Bureau of Economic Research has examined how basic research generates spillovers and why firms may have weaker incentives to finance research whose benefits are difficult to appropriate.

Science donations help bridge this difference between capturable value and social value.

Donations Are Voluntary Market Coordination

A science donation is not outside the market merely because the donor does not expect a direct financial return.

People routinely spend money to obtain outcomes they value:

• education;
• environmental protection;
• open-source software;
• religious or cultural activity;
• care for vulnerable people;
• scientific progress.

The desired outcome itself is part of the donor’s utility.

A donor may value a cure becoming possible, a mathematical theory being developed, an open dataset being published, or a neglected researcher receiving the resources needed to work. Paying for that outcome is a voluntary economic decision.

This makes research philanthropy a form of voluntary coordination. Donors express preferences by allocating their own resources toward projects they consider beneficial.

The transaction differs from ordinary consumption because the benefit may be distributed widely rather than reserved for the purchaser. But the decision remains decentralized and voluntary.

A Free Market Needs Pre-Commercial Research

Commercial innovation rarely begins from nothing. Companies build products on top of earlier discoveries, including:

• mathematical results;
• scientific instruments;
• physical theories;
• chemical methods;
• medical research;
• public datasets;
• programming languages;
• open-source libraries;
• technical standards.

Much of this foundation is too early, uncertain, or general to support a conventional business model.

Private companies are often excellent at transforming sufficiently mature knowledge into scalable products. They are less naturally positioned to finance every distant prerequisite from which competitors may also benefit.

This creates a division of economic functions:

1. Open and philanthropic research expands the possibility space.
2. Entrepreneurs identify commercially useful applications.
3. Companies combine knowledge, labor, and capital into products.
4. Competition improves delivery and lowers costs.

Research funding therefore need not replace entrepreneurship. It can supply entrepreneurs with more ideas, tools, discoveries, and technological options.

Economic research reviewed by the NBER has found that public basic research can make private research more productive and increase private R&D under appropriate conditions. This is commonly described as a crowding-in effect rather than crowding out.

The same logic can apply to donations. Funding open research may create inputs that many competing firms can later use.

Science Donations Expand Entrepreneurial Opportunity

Concentrated ownership of knowledge can support investment when exclusivity is necessary to recover development costs. Patents and trade secrets therefore have legitimate economic roles.

But excessive dependence on proprietary research can also create barriers:

• new firms must duplicate existing work;
• researchers cannot inspect hidden methods;
• interoperability becomes harder;
• foundational tools remain locked inside large institutions;
• entrepreneurs need permission before experimenting;
• knowledge monopolies can accumulate around essential techniques.

Openly funded science can reduce these barriers.

When research outputs are genuinely accessible, startups and independent developers can build on them without negotiating with every previous contributor. This lowers entry costs and expands the number of people capable of attempting new ventures.

Thus, science donations can strengthen competition in two ways:

• by increasing the stock of usable knowledge;
• by preventing all foundational knowledge from being controlled by a few incumbent firms.

A stronger commons at the research layer can support more competition at the product layer.

Decentralized Funding Improves Donor Choice

Recognizing a funding gap does not prove that a single central authority should decide what research deserves support.

Government agencies can fund projects that markets overlook, but centralized systems introduce their own problems:

• political influence;
• administrative overhead;
• conservative review committees;
• preference for established institutions;
• dependence on credentials and institutional prestige;
• slow grant cycles;
• difficulty evaluating unconventional work;
• vulnerability to changing national priorities.

The OECD explicitly recognizes public research as important when private initiative is insufficient, but this does not imply that public agencies always allocate funds optimally.

A resilient research economy should permit multiple allocation mechanisms:

• government grants;
• corporate R&D;
• universities;
• private foundations;
• crowdfunding;
• research prizes;
• individual donations;
• decentralized autonomous organizations;
• algorithmically assisted funding systems.

This is institutional competition applied to science.

When donors can compare projects, funding rules, outcomes, and governance systems, research organizations must compete for credibility. Poorly performing intermediaries can lose support while better mechanisms attract more resources.

Why Decentralization Matters

Traditional research philanthropy often remains centralized. Donors transfer money to a foundation, university, or charity whose managers decide how the funds will be used.

Decentralized research funding attempts to distribute some of these decisions across transparent technical and governance systems.

A decentralized platform may provide:

• public records of incoming donations;
• visible allocation rules;
• auditable transactions;
• open project submissions;
• distributed evaluation;
• milestone-based payments;
• post-publication assessment;
• global participation;
• reduced dependence on one university or state.

Blockchain technology does not automatically make funding fair or intelligent. A poorly designed DAO can reproduce popularity contests, wealthy-donor dominance, speculative incentives, or weak scientific evaluation.

The important economic advantage is not the word blockchain. It is the possibility of creating verifiable rules and competing funding institutions.

Science DAO describes itself as a decentralized platform for funding open scientific research and making funding decisions traceable on-chain.

Its broader relevance is that it explores how scientific philanthropy could become more transparent, programmable, and globally accessible.

Decentralization Reduces Single-Committee Risk

Centralized grant systems create a concentrated point of failure.

When a small committee rejects a project, the project may have no realistic alternative source of support—especially when the researcher lacks an institutional affiliation, prestigious credentials, or a conventional research topic.

A decentralized system can allow different donors and evaluators to support different types of work. One funding pool may prioritize immediate applications; another may fund foundational mathematics; another may support replication, open data, or free software.

This resembles portfolio diversification.

In finance, concentrating all capital in one asset increases risk. In science, concentrating all judgment in one committee creates an analogous epistemic risk. The committee may be competent, but no committee is guaranteed to recognize every important unconventional idea.

Multiple funding mechanisms allow society to make many smaller, independent bets.

Donations Can Finance High-Risk, Long-Horizon Research

Markets usually price risk in relation to expected private returns. Scientific projects may be highly valuable but commercially unattractive because:

• success is difficult to predict;
• practical applications may take decades;
• the researcher cannot patent the result;
• the outcome may invalidate rather than produce a product;
• the work may consist of replication or error detection;
• benefits may occur in countries that did not fund the work;
• the result may become basic infrastructure used by competitors.

Donations can tolerate these conditions because donors may optimize for social impact rather than financial capture.

This does not mean donors should ignore evidence or fund every speculative proposal. It means they can use a broader objective function.

A commercially rational question is:

How much profit can this project return to us?

A philanthropic research question is:

How much useful knowledge could this project create for society?

Both questions are legitimate. A healthy market economy needs institutions capable of asking each one.

Scientific Failure Can Still Produce Economic Value

Commercial investors understandably prefer projects with identifiable deliverables. Science is more difficult because a properly conducted experiment may fail to confirm its hypothesis.

Yet a negative result can still be valuable.

It may:

• prevent other researchers from repeating an unproductive approach;
• reveal limitations in an established model;
• redirect investment toward better alternatives;
• identify safety problems;
• improve measurement techniques;
• narrow the range of plausible explanations.

The problem is that these benefits are widely dispersed. The organization paying for the failed experiment may bear the full cost while competitors learn from the result.

This makes negative results particularly vulnerable to underfunding and non-publication.

Donation-funded open science can support the production and publication of such information, reducing duplication across the economy.

Decentralized Research Funding Can Complement Prices

Price signals are powerful, but they operate only where prices can be formed.

There may be no meaningful market price for:

• a theorem that will become useful in 30 years;
• an open replication of an influential experiment;
• a dataset freely released to everyone;
• the discovery that an accepted method is unreliable;
• a conceptual framework with no immediate industrial application;
• maintenance of obscure but critical scientific software.

The absence of a market price does not imply that these outputs have no economic value. It often means that ownership and payment cannot be matched cleanly to beneficiaries.

Decentralized donations create an additional signal: people voluntarily commit resources to work whose value is not represented adequately by product revenue.

These signals should not be treated as perfect. Donation volume may reflect publicity, emotional appeal, or donor wealth rather than scientific merit. However, conventional grant systems and commercial investment also contain biases.

The appropriate goal is not to identify one flawless allocator. It is to build a pluralistic system in which different mechanisms correct one another’s weaknesses.

The Role of AI-Assisted Funding

A decentralized funding system still faces a difficult question: how should money be distributed among competing researchers and projects?

Simple voting can become a popularity contest. Expert committees can reproduce institutional gatekeeping. Token-weighted governance can allow wealthy participants to dominate.

Science DAO proposes an approach called AI Internet-Meritocracy, or AIIM, which would evaluate evidence of contribution and help allocate donated resources according to assessed impact. Its stated objective is to support scientists and free-software developers using publicly inspectable evidence rather than relying exclusively on institutional status.

The proposal should be understood as an experimental governance model, not as proof that artificial intelligence can determine scientific value perfectly.

Any credible AI-assisted allocation system would need:

• transparent evaluation criteria;
• auditable input data;
• safeguards against gaming;
• mechanisms for appeals and corrections;
• uncertainty estimates;
• protection against citation and prestige bias;
• human oversight for ambiguous cases;
• regular testing for unintended incentives.

The potential benefit is scalability. A well-designed model could examine more projects and more dimensions of contribution than a small grant committee. The risk is that hidden assumptions become automated.

Transparency is therefore indispensable.

Decentralization Is Not the Same as Deregulation

A free-market defense of research donations should not claim that all regulation, public funding, or institutional oversight is unnecessary.

Scientific activity can involve safety, privacy, environmental, medical, and ethical risks. Research funding also creates opportunities for fraud and conflicts of interest.

Decentralization does not eliminate the need for:

• research ethics;
• financial accountability;
• legal compliance;
• conflict-of-interest disclosure;
• scientific review;
• protection of participants;
• accurate reporting.

The stronger claim is narrower:

Research funding should not be monopolized by one class of institution when voluntary, transparent, and decentralized alternatives can increase experimentation and accountability.

Decentralization is valuable when it expands choice and distributes authority—not when it removes every safeguard.

How Science Donations Strengthen Market Economies

Science donations contribute to market economies through several connected mechanisms.

1. They increase the stock of productive knowledge

New knowledge can improve products, manufacturing, medicine, agriculture, energy, computing, and organizational methods.

2. They finance inputs that firms cannot fully appropriate

Basic discoveries and open tools may benefit entire industries rather than one investor.

3. They lower barriers to entrepreneurship

Open research gives new firms access to knowledge that might otherwise remain concentrated inside large corporations or universities.

4. They diversify economic experimentation

Independent researchers can pursue ideas overlooked by dominant institutions.

5. They reduce duplication

Open publication of methods, data, and negative results allows others to avoid repeating failed work.

6. They create competition among funding institutions

Donors can compare government agencies, universities, foundations, crowdfunding platforms, and DAOs.

7. They support long-term growth

Scientific progress expands what future entrepreneurs can build, even when no immediate product is available.

These are not anti-market effects. They improve the environment in which markets operate.

The Difference Between Supporting Markets and Subsidizing Companies

Funding open science is different from transferring public or charitable money directly to a favored corporation.

A company subsidy may protect an incumbent, distort competition, or socialize costs while privatizing profits.

Open research funding can produce a more neutral result when:

• findings are publicly accessible;
• several firms can use them;
• research methods are disclosed;
• data and software are released under open terms;
• funding decisions are transparent;
• no single company receives exclusive control without justification.

The distinction is crucial.

The strongest free-market case concerns funding shared productive infrastructure, not selecting politically connected corporate winners.

Knowledge can function like infrastructure. Roads permit many businesses to transport goods; open scientific knowledge permits many businesses to develop products.

Is Donating to Science Economically Rational?

Yes—provided the donor values the wider outcome and exercises reasonable due diligence.

Economic rationality does not require every payment to produce personal financial profit. People rationally spend money on outcomes they value, including outcomes shared with others.

A science donor can reasonably ask:

• Is the research question important?
• Is the methodology credible?
• Will results be published openly?
• Are funding decisions transparent?
• Can the project report measurable progress?
• Does the platform disclose fees and conflicts of interest?
• Can independent researchers inspect the outputs?
• Is the project filling a genuine funding gap?

These questions help distinguish productive philanthropy from vague scientific branding.

A Market Economy Needs More Than Profit-Seeking Capital

Profit-seeking investment is indispensable. It disciplines costs, tests consumer demand, and scales useful products.

But profit is not a complete measurement of social value.

Some activities create value that cannot be fully captured in a sale. Fundamental science is among the clearest examples. Its outputs often spread across firms, industries, countries, and generations.

A market economy that neglects these foundations may remain efficient at distributing existing products while becoming progressively worse at generating new possibilities.

Science donations address that weakness through voluntary action.

They allow individuals and organizations to fund the upstream knowledge from which future markets emerge.

Conclusion: Science Donations Are Market-Building Capital

The free-market argument for science donations does not depend on hostility toward business, private property, or entrepreneurship.

It begins with a standard economic observation: knowledge spillovers cause private investors to capture less value than scientific research creates for society.

As a result, socially valuable research is underproduced.

Voluntary donations, open-science foundations, prizes, crowdfunding, and decentralized research platforms can help correct this underproduction. They finance pre-commercial knowledge, widen entrepreneurial access, diversify experimentation, and create competition among research-funding institutions.

Decentralized systems add a further possibility: donors may be able to inspect allocation rules, trace transactions, and support researchers without passing through a single university, corporation, or government committee.

These systems still require rigorous governance, scientific evaluation, and protection against manipulation. They are complements to commercial R&D and public funding, not magical replacements for every institution.

The central principle is nevertheless strong:

Donating to open science is not a rejection of markets. It is an investment in the shared knowledge infrastructure that makes future markets possible.

Readers interested in supporting this approach can examine Science DAO’s model for decentralized scientific funding, its proposal for AI-assisted research allocation, and its science donation program.